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Summary 
Only a fraction (12%) of 268 "autoreactive" T  cell clones derived from lupus-prone mice can 
selectively induce the production of pathogenic anti-DNA autoantibodies in vitro and accelerate 
the development of lupus nephritis when transferred in vivo. The CDR3 loops of T cell receptor 
B chains expressed by these pathogenic T helper (Th) clones contain a recurrent motif of anionic 
residues  suggesting that they are selected by autoantigens with cationic residues.  Herein, we 
found that =50%  of these pathogenic Th clones were specific for nucleosomal antigens, but 
none of them responded to cationic idiopeptides shared by variable regions of pathogenic anti- 
DNA autoantibodies. Nucleosomes did not stimulate the T  cells as a nonspecific mitogen or 
superantigen. Only the pathogenic Th cells of lupus responded to nucleosomal antigens that 
were processed and presented via the major histocompatibility class II pathway. Although the 
presentation of purified mononucleosomes to the Th clones could be blocked by inhibitors of 
endosomal proteases, neither of the two components of the nucleosomes-free DNA or histones 
by themselves-could stimulate the Th clones. Thus critical  peptide epitopes for the Th cells 
were probably protected during uptake and processing of the nucleosome particle as a whole. 
The nucleosome-specific Th clones preferentially augmented the production of IgG autoantibodies 
to  histone-DNA  complex in  vitro.  In  vivo,  nucleosome-specific,  CD4 +  T  cells  were not 
detectable in normal mice, but they were found in the spleens of lupus-prone mice as early as 
I mo of age, long before other autoimmune  manifestations. Immunization  of young, preautoimmune 
lupus mice with nucleosomes augmented the production of autoantibodies and markedly accelerated 
the development of severe glomerulonephritis. Previously, crude preparations containing nucleosomes 
were shown by others to have polyclonal mitogenic activity for B cells from normal as well 
as lupus mice. Identification here of pure mononucleosome as a lupus-specific immunogen for 
the Th cells that selectively help the pathogenic anti-DNA autoantibody producing B cells of 
lupus could lead to the design of specific therapy against this pathogenic autoimmune response. 
T 
he cause and cure of SLE remains elusive because the 
primary autoantigen(s) that drives the pathogenic au- 
toimmune response in this disease is unknown. The patho- 
genic anti-DNA autoantibodies that are consistently found 
in the renal lesions of lupus (1-3) and cause immune deposit 
nephritis when administered in vivo (4, 5) appear to be the 
products of an antigen-driven immune response:  i.e.,  they 
have undergone clonal expansion with IgG class switch and 
somatic mutations that generated cationic residues in their 
V, regions (5-10).  This pathogenic autoantibody response 
in both spontaneous and experimentally induced (graft-vs.- 
host) SLE is Th cell dependent and these Th cells are pre- 
dominantly CD4 + (11-19). We have cloned such special au- 
toimmune Th  cells  from  patients  as  well  as  (SWR  x 
NZB)F1 (SNF1) mice with lupus nephritis. In marked con- 
trast to the autoimmune NZB and the normal SWR parental 
strains,  the SNF1 progeny uniformly produce pathogenic 
anti-DNA autoantibodies under the influence of certain Th 
cells and develop severe lupus glomerulonephritis (2, 12, 20). 
Only 12% of 268 "antoreactive" T cell clones derived from 
10 nephritic SNF1 mice and, similarly, a mere 15% of =400 
autoreactive  T  cell  clones  from  five patients with  lupus 
nephritis have the functional ability to selectively induce the 
production of pathogenic anti-DNA autoantibodies in vitro 
when cultured with syngeneic B cells (21-23). Moreover, rep- 
resentative pathogenic autoantibody-inducing Th clones de- 
rived from the nephritic SNF1 mice rapidly induce immune 
deposit glomerulonephritis when transferred  in vivo into 
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tral importance in lupus is what autoantigen drives these patho- 
genic Th cells? Although DNA is a target antigen for the 
pathogenic anti-DNA autoantibodies, immunization with 
DNA does not lead to the development of SLE (25). We found 
that the V-D-J junctional regions (CDR3) of TCR 13 chains 
expressed  by these pathogenic Th clones bear a recurrent 
motif of one or more anionic residues that are generated by 
N-nucleotide additions. This result suggested that the patho- 
genic Th clones of lupus may be selected by some autoan- 
tigen(s) with cationic residues (24). The importance of recipro- 
cally charged residues in TCR-CDR3 and antigenic peptide 
interaction has been recently established  in another system 
(26). Since the pathogenic Th clones of lupus preferentially 
help the select population of B cells that produce the patho- 
genic anti-DNA autoantibodies, it is likely that those au- 
toimmune B cells in turn present the autoantigen(s) with 
cationic residues to these Th cells (see Fig. 1). Cationic pro- 
teins, such as, histones complexed with DNA could be taken 
up,  processed,  and  presented  by  such  anti-DNA  B  cells 
efficiently, as demonstrated in other antigenic systems  (for 
a review see reference 27).  Alternatively, peptides with cat- 
ionic residues derived from the V regions of their endoge- 
nous, anti-DNA Ig (idiopeptides) could be presented by the 
anti-DNA B cells to the pathogenic Th cells (28).  Herein, 
we tested the responsiveness of the pathogenic Th clones for 
some candidate autoantigens based on these hypotheses. 
Materials and Methods 
M~  BALB/c,  C57BL/6, NZB, SWR, and (NZB x NZW)F1 
(BWF1) mice were from The Jackson Laboratory (Bar Harbor, 
ME). (SWR  x  NZB)F1 (SNF1) hybrids were bred at Tufts An- 
imal Facility. Female mice were used for the studies. 
Antibodies.  The  following  mAbs: TIB120/M5  broadly  re- 
active against I-A  TM and FEd'k; anti-I-Aa-HB3/MKD6, anti-J11d- 
TIB183, anti-Thy-l.2-TIB99,  anti-CD4-RL-172.4, anti-CD8-TIB211, 
and anti-CD3-145-2C11, were obtained from the American Type 
Culture Collection ([ATCC] Rockville, MD. References in cata- 
logue). The anti-I-A  b mAb HB38 (29), and the anti-TCR V136 
mAb 44-22-1 (30), were gifts from Brigitte Huber (Tufts Univer- 
sity). The anti-Ib4 mAb 11Bll (31), and the anti-Ib2 mAb $4B6 
(ATCC), were gifts from Dr. Miguel Stadecker (Tufts University). 
The anti-I-E  a mAb 14-4-4S (32), was from Dr. Laurie Glimcher 
(Harvard University, Cambridge, MA). The anti-I-Aq  mAb MKQ7 
(derived from BALB/c immunized with SWR B cells) was a gift 
from Dr. Phillipa  Marrack  (National  Jewish Center for Immunology, 
Denver, CO). All mAbs were concentrated 10 times by 47% satu- 
rated ammonium sulfate (SAS) cut of hybridoma culture superna- 
rants, dialyzed, and used at final dilutions, as specified. 
Antigens.  Pure  mononucleosomes were prepared as described 
(32). Briefly, the nucleosomes were isolated by solubilizing chro- 
matin from purified chicken erythrocyte nuclei with micrococcal 
nuclease (Worthington Biochem. Corp., Freehold, NJ). The solu- 
bilized chromatin was then stripped of H1, H5, and HMG pro- 
teins by gel filtration on CM sephadex C-25-120 (Sigma Chemical 
Co., St. Louis, MO). Stripped chromatin was then redigested with 
micrococcal nuclease and mononucleosomes were isolated by gel 
filtration on sephacryl S-400 (Pharmacia LKB, Piscataway, NJ), 
eluted with 5 mM Tris pH 8.0, 0.2 mM EDTA, and 20 mM NaC1. 
Column fractions were analyzed for monomers by PAGE of DNA 
and appropriate fractions were pooled (see Fig. 2 A). Histone-gel 
analysis showed  the mononucleosome  preparation to consist of  core 
histones (see Fig. 2 B). "Nucleohistone" from calf thymus was pur- 
chased from Sigma Chemical Co. and was slowly dissolved  in PBS 
by constant stirring for 1 wk (33, 34). Any insoluble material was 
removed by centrifugation at 2,000 g for 10 min. Gel electropho- 
resis of the above preparation showed the presence of oligo- and 
polynucleosomes.  The DNA concentration  of  all nucleosome  prepa- 
rations was estimated by the diphenylamine reagent method (35). 
Calf thymus DNA (Sigma Chemical Co.) at various concentra- 
tions was used to develop a standard curve. 
Histone octamers  were prepared from core mononucleosome  par- 
tides as described (36). Core particles  were concentrated in a stirred 
cell (Amicon Corp., Danvers, MA) with an XM 50 membrane, 
and then further concentrated in a Centricon (Amicon Corp.) 30 
to 1000 A~0 Units per 1.8 ml. An equal volume of 4.4 M NaC1, 
0.2 M KPO4, pH 6.7 was added to the particles, followed by 
loading onto a hydroxyapatite column equilibrated with 2.2 M 
NaC1, 0.1 M KPO4, pH 6.7. Am monitoring  indicated where 
peak fractions eluted, and the quality was further checked by run- 
ning on a Laemmli 15% polyacrylamide-SDS  gel. The nucleosome 
and histone octamer preparations were stored at 4~  The other 
histone preparations and heparan sulphate were purchased from 
Sigma Chemical Co. 
Synthetic  peptides: CDtL1 (TFTSYWMHWVKKRPGQGLE), 
CDR2 (NPSNGRTNYNEKFKRKAT),  and a control  peptide 
(WINTNTGEPTYAEEFKG) were synthesized  by T-boc chemistry, 
purified by HPLC, sequenced, and verified to be ;>95% pure at 
the Tufts University peptide synthesis facility. The CDR1 and 
CDR2 peptides correspond to positions 28-46 and 52-69, respec- 
tively, of the CDR and flanking sequences of the V. region that 
is shared by the major Id564 family of nephritogenic anti-DNA 
autoantibodies of SNF1 mice (2, 4, 7). These CDR peptides also 
contain T cell epitope motifs (37). The control peptide corresponds 
to the CDR2 (position 50-65) of an irrelevant antimalarial anti- 
body (38). 
T  Cell Clones.  The seven cloned Th lines and eight Th hy- 
bridoma clones used in this study were derived from nephritic 
SNF1 mice, subcloned, and maintained as previously  described (21, 
22, 24). Two of these previously characterized Th cell lines were 
growing poorly. They were therefore immortalized by fusion with 
the oe/~ TCR- variant of BW5147 thymoma as described (24). 
In addition, 52H10.Fll is an insulin-specific  T cell hybridoma de- 
rived from C57BL/6 (39), a gift from Brigitte Huber. For prolifer- 
ation assays, T cells (lines) that had been rested for 7-10 d from 
their last feeding  regimen  were purified  by centrifugation  over Ficoll- 
Paque  (Pharmacia LKB, Uppsala, Sweden)  to  remove dead 
cells/feeders. The enriched  ILPMI  medium for growing and assaying 
the function of the Th clones has been described (21, 22) and will 
be referred to as final medium. 
Isolation of Splenic T  Cells.  Whole spleen cells from which 
erythrocytes had been removed by hypotonic lysis were depleted 
of  B cells  by one cycle  of panning (22). The nonadherent ceils were 
further purified for CD4 + T cells by two rounds of antibody/com- 
plement treatment as described (21, 40). Spleen  cells  were suspended 
at 20  x  106/ml in serum-free RPMI medium containing a cock- 
tail of antibodies: anti-CD8 (1:4), anti-Ia (1:4), and anti-Jlld (1:10) 
for 30 min on ice. The broadly reactive anti-Ia mAb, TIB120, was 
used for all the  preparations. In addition,  the anti-I-A  a mAb, 
MKD6,  was  used for  preparing T  cells from  NZB, BALB/c, 
BWF, and SNF1 strains, whereas the anti-I-A  b mAb, HB-38, was 
used for isolating T cells from C57BL/6. Antibody treatment was 
followed  by incubation with a mixture of rabbit (1:20) and guinea 
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for 45 min. The isolated T  cells were shown to be >95%  pure 
by flow cytometry. For the isolation of CD8 + T  cells, the anti- 
CD4 mAb was substituted for the anti-CD8 mAb. 
Preparation of Splenic APCs.  Whole spleen  cells depleted of 
erythrocytes  were  incubated  at  20  x  106/ml  in  serum-free 
medium containing anti-Thy 1.2 (1:4) for 30 min on ice, followed 
by rabbit complement (1:5) at 37~  for 45 min. The APCs (1.5 
x  106 in 200 #1) were either sham- or antigen-pulsed at 37~  for 
2 h, and then washed three times,  irradiated (3,000 tad), washed 
again,  and cocultured at 5  x  10S/well with T cells in 200 gl final 
medium in 96-weU plates  (Costar Corp., Cambridge, MA). 
Other APCs.  The L cell transfectants (gifts of Kon Germain, 
National Institute of Allergy and Infectious Diseases,  Bethesda, 
MD): KT2.3.3HD6 (Act~Afld), KT 10.3B-C1 (Ed), KT 7.7H714.3 
(EotdAfla), FT 7.1C6 (Ac~bAflS), and the A20 B cell lymphoma 
(ATCC), were used as described (41, 42). These APCs were either 
sham- or antigen-pulsed for 18 h, washed three times, irradiated 
(18,000 tad), washed again, and then cocultured with the Th clones 
at a density of 5  x  104/well (L cells) or 2  x  10S/well (A20). 
Proliferation Assays.  Each Th clone (10S/well) or fresh splenic 
T  cells (5  x  10S/well) were cocultured in triplicate with irradi- 
ated, antigen- or sham-pulsed APCs in 200 gl final medium in flat- 
bottomed 96-well tissue culture plates (Costar Corp.) for 72 h. 6 h 
before harvesting,  1 gCi of [3H]thymidine in 25 gl culture me- 
dium was added to each well. Incorporated radioactivity was mea- 
sured in cpm as described (21, 22). As positive controls for stimula- 
tion,  the anti-CD3  mAb was  used,  Stimulation index (SI)  1 for 
proliferation was calculated by dividing the mean cpm incorpo- 
rated in cultures of T cells plus antigen-pulsed APC by the mean 
cpm in T  cells plus sham-pulsed APC cocultures. 
Blocking of Proliferation.  All 10x  concentrated mAb used for 
blocking T cell proliferative responses were added at 1:4 final dilu- 
tion to the irradiated, antigen-pulsed APCs from 30 min before 
the  addition  of T  cell  clones  and  were  left  in  the  coculture 
throughout the 72-h period. Chloroquine (0.3 mM, Sigma Chem- 
ical Co.) was added to the APCs throughout the antigen pulse, 
after which the APCs were washed, irradiated, and used (43). The 
protease inhibitors, leupeptin and pepstatin A (Sigma Chemical Co.) 
were added to the APCs at 0.5 and 0.1 mM, respectively, before 
the  commencement  of antigen  pulsing,  and  were  maintained 
throughout the 72-b assay period, as described (44). For fixation, 
the APCs were exposed to 0.5% paraformaldehyde (Sigma Chem- 
ical Co.) for 30 s and promptly quenched with 0.2 mM glycine, 
washed twice in KPMI-10% FCS, incubated at 37 ~ for 30 min, 
and rewashed two more times before antigen pulsing or coculture 
with T  cells. 
IL Production by T  Hybridomas.  2  x  104 Th hybridoma cells 
growing in log phase were cocultured with irradiated, antigen- 
or sham-pulsed  APC, with either 2  x  10  s A20 B lymphoma cells 
per well or with 5  x  105 SNF1 splenic APCs/well in 200 gl final 
medium in flat-bottomed 96-well plates (Costar Corp.). After 24 h, 
100 gl of culture supernatant was harvested from each well, freeze- 
thawed and added to 2  x  104 HT-2 (Ib2 and/or I1r  dependent 
cell line,  gift from Brigitte Huber) ceils per well. After an 18-h 
incubation, I gCi [3H]thymidine was added to each well. 6 h later, 
radioactivity incorporated by the  HT-2 cells  was  measured.  IL 
production in response to anti-CD3 stimulation, served as a posi- 
tive control. SI for interleukin production was calculated by dividing 
1 Abbreviations used in this paper: BUN, blood urea nitrogen; MHCII, 
MHC class II; SAS, saturated ammonium sulfate; SI, stimulation index. 
mean cpm in HT-2 cells incubated with culture supernatants from 
T  hybridoma cells plus antigen-pulsed APC by that from T  hy- 
bridoma plus sham-pulsed APC. 
IL  Secretion Profiles.  Supernatants  harvested from anti-CD3 
stimulated Th clone cultures at 24 h were freeze-thawed and added 
in serial dilutions to 2  x  104 HT-2 cells/well in the presence  or 
absence of 10 gl of anti-Ib2 (10x  concentrated) and/or 2.5 gl of 
anti-IL-4  (10x) mAbs.  [3H]Thymidine incorporation during the 
last 6 h of a 24-h culture was determined, and compared with re- 
sponses elicited by known amounts of murine rib4 (gift of Brigitte 
Huber) or rlL-2 (Cetus, Emeryville, CA) in the presence or ab- 
sence of the anti-IL mAbs. 
Help for Autoantibody Production In Vitro  SNFI splenic T cells 
or Th clones were cocultured with SNF1 splenic B cells (plus mac- 
rophages) for 7 d according to previous procedures (12, 21). On 
day 7, culture supernatants were harvested, freeze-thawed, and as- 
sayed by ELISA for antibodies produced against ssDNA, dsDNA, 
histones, and histone-DNA complex. For these ELISAs, the su- 
pernatants were purified by 47% SAS cutting (12, 13, 21), dialyzed 
and used as described below. 
ELISA.  Total IgG and IgG class autoantibodies to ssDNA and 
dsDNA produced in helper assay coculture supernatants or in the 
sera of in vivo injected mice (see below) were measured by ELISA, 
as described (12, 13, 21), with one modification: for the anti-dsDNA 
assay, purified calf thymus DNA (Sigma Chemical Co.) was first 
sheared to 400-800 bp by sonication and digested with $1 nuclease 
before use. For the anti-ssDNA assay, this same preparation was 
boiled for 15 rain and chilled  on ice before use. 
IgG class antibodies against  histones and histone-DNA com- 
plex were measured as described (45-47). Briefly, 96-well  plates 
were coated with 10 gg/ml total histones (Sigma Chemical Co.) 
overnight.  For  the  antihistone-DNA  complex  assays, mBSA 
precoated plates were first coated with dsDNA (50 gg/ml) over- 
night, and then with total histones at 10 gg/ml overnight. This 
procedure gave more specific results than coating the wells directly 
with nucleosomes (46, 47). All remaining steps from the addition 
of test sample were identical to those of the anti-DNA ELISA (12, 
13, 21). All samples were serially diluted and tested in triplicate. 
For subtraction of  background binding, supematants from Th clones 
cultured by themselves or serum from nonautoimmune AKK mice 
were used. Standard curves for each assay were obtained with known 
quantities of anti-DNA mAbs 564 and 205 as described (12, 21). 
For IgG autoantibodies to ssDNA,  histones,  and histone-DNA 
complex, 1 U/ml was considered to be equivalent to the activity 
of I/~g/ml of mAb 564, which bound to all the three antigens 
(see below) and for IgG anti-dsDNA,  1 U/ml was equivalent to 
the binding of 0.6 gg/ml of the mAb 205. 
In some experiments, the anti-DNA mAbs were digested with 
DNAse, dialyzed into high molarity NaC1 (2 M), and then redia- 
lyzed into the ELISA sample buffer by Centricon (Amicon Corp.) 
before testing for binding to the above antigens or to histones that 
had been also digested with DNAse before coating onto ELISA 
plates,  as described (48). 
Pathogenicity of Nucleosomes In  Viva  2-mo-old SNF1 females 
were injected intraperitoneally three times, 2 wk apart, with ei- 
ther mononucleosomes (7 mice) or PBS (15 mice).  For the first 
injection, nucleosomes (10/~g in 50 gl PBS/monse) or PBS (50 
/zl/mouse) was mixed 1:1 with CFA (Gibco Laboratories,  Grand 
Island,  NY), whereas the remaining two boosters were in IFA. 
The mice were monitored weekly for proteinuria by albustix (20), 
and killed when they developed persistent proteinuria (defined as 
two consecutive weekly recordings of 300 mg/dl or greater). Sera 
was collected after killing for determination of blood urea nitrogen 
1369  Mohan et al. Figure  1.  The pathogenic  anti-DNA  autoantibodyqnducing  Th dones 
have negatively  charged  residues  (solid  white)  in the CDR3 of their TCR 
chains. The Th clones  could  be specific  for either  a peptide  with cationic 
residues (black, inside  white  border)  derived  from a DNA-binding  protein 
that is endocytosed  with anionic  DNA, processed,  and presented  to the 
Th cells  by the anti-DNA  B cells  (left),  or a cationic  idiopeptide  processed 
from the V, regions  of the pathogenic  anti-DNA autoantibodies  produced 
by these B cells (right). This hypothetical  scheme  could also explain the 
preferential  interaction  between  these  Th cells  and the cationic  anti-DNA 
autoantibody-producing  B cells. (Ia) MHC class II molecule. 
(BUN) by azostix and measurement of IgG antibodies to ssDNA, 
dsDNA, total histones, and histone-DNA complex by ELISA. Sec- 
tions from the kidneys were stained for detection and grading of 
glomerulonephritis by light microscopy, and immunofluorescence 
of frozen sections to detect the degree of IgG immune complex 
deposits was done as described (20, 24, 49). 
Results 
A  Summary of  the Properties  of  Pathogenic  Autoantibody-inducing 
Th Clones.  In previous work, we had cloned 268 T cell lines 
and hybridomas from the T  cells that were spontaneously 
activated in vivo in the spleens of 10 SNF1 mice with lupus 
nephritis. Only 12%  of these T  cell clones had the ability 
to preferentially augment the production of IgG anti-DNA 
autoantibodies when cultured with syngeneic B cells (22, 24). 
Most of these Th clones were CD4 +. Two of these cloned 
lines, L-1A and L-3A, had also been tested for pathogenicity 
in vivo, and they rapidly induced lupus nephritis upon transfer 
into preautoimmune SNF1 mice (24).  A recurrent motif of 
anionic residues that were generated mostly by N nucleotide 
additions, were found in the CDR3 junctions of the TCR 
/3 chains expressed by these Th dories (summarized in Fig. 
3 from data in reference 24).  15 of these Th clones with the 
strongest autoantibody-inducing ability were studied here for 
their antigenic specificities,  and their previously published 
features are summarized in Fig. 3. Herein, we also determined 
the interleukin production profile of the Th clones upon stim- 
ulation with anti-CD3 mAb.  11 of the 15 Th dories pro- 
duced IL-2, but not IL-4 (Thl type); three produced IL-4, 
not IL-2 (Th2 type), and one Th done made both interleukins 
(Th0 type). 
Pathogenic Th Clones Do Not Respond to Autoantibody  V, 
Region Peptides or to Helmran Sulphate Proteoglycan.  The Th 
clones have anionic residues in their TCR V3-CDR3  sug- 
gesting that they may be specific for peptides with cationic 
residues and they preferentially help the B cells that produce 
an idiotypically connected set of cationic anti-DNA autoan- 
tibodies with homologous V. but heterogeneous V~ regions 
(2, 7, 21, 24). Hypothetically, those anti-DNA B cells could 
process and present to the Th clones their endogenous idio- 
peptides containing stretches of cationic residues in and adja- 
cent to the CDR1  and CDR2  of the V. region that they 
share (7). The two synthetic peptides corresponding to these 
regions also contained T cell epitope motifs (37).  A control 
peptide  corresponding to  the CDR2  of an  irrelevant an- 
timalarial antibody (38) was also tested. Alternatively, since 
anti-DNA autoantibodies have been shown to cross-react with 
other polyanions besides DNA, such as heparan sulphate which 
is the major proteoglycan in the glomerular basement mem- 
branes (50),  the anti-DNA B cells could process such an an- 
tigen for the Th clones with which they interact. Heparan 
sulphate,  although  predominantly  anionic,  does  contain 
stretches of cationic residues (51). The synthetic CDR pep- 
tides ranging in concentration from 10 -3 to 103/zM,  or the 
intact pathogenic anti-DNA mAbs recurrently expressed by 
nephritic SNF1 mice (2, 4, 7) at 1-10/zg/ml, or calf thymus 
DNA  or heparan sulphate (0.1-10/zg/ml)  were tested for 
stimulating the Th clones with appropriate APC. These Th 
clones are autoreactive, i.e.,  they spontaneously respond to 
splenic APC from older SNF1 mice (21). However, we found 
that splenic APC from very young, 1-mo-old SNF1 mice did 
not induce significant autoreactive proliferation of the Th 
clones and these APC were used for the assays. Among the 
Th clones, the lines were tested for proliferation and the Th 
hybridomas  for  IL  production.  None  of  the  Th  clones 
responded to any of these candidate autoantigens either when 
they were used to pulse the APC or when they were left in 
continuous culture with the APC (data not shown). 
Pathogenic Autoantibody-inducing Th Clones Respond to Nu- 
cleosomes.  8 of the 15 Th clones shown in Fig. 3 responded 
to APC that were pulsed with either purified mononucleo- 
somes or the "nucleohistone" preparation (Sigma Chemical 
Co.)  containing  nucleosome multimers  (Tables  1  and  2). 
Results obtained with purified mononucleosomes are shown. 
The cloned Th lines are shown in Table 1. A nonantoantibody- 
inducing, autoreactive T cell line, L-5A (uses VB1/J~2.1 TCR 
genes), that is also derived from a nephritic SNF1 mouse (21, 
22,  24),  is included. The nucleosome preparations did not 
stimulate any of the Th clones directly and the nucleosome- 
pulsed APC after washing and irradiation did not proliferate 
or produce ILs by themselves (Tables 1 and 2). Three of the 
pathogenic Th lines responded significantly. In the case of 
two of the cloned lines,  L-3A and L-9.37,  the proliferative 
responses to nucleosomes were as high as that to anti-CD3 
mAb. The background SI for proliferation of these Th clones 
were calculated by averaging their responses to the synthetic 
V, region peptides, intact autoantibodies, DNA or heparan 
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PAGE of DNA in eluted column 
fractions. Mono- and dinucleosome 
bands are indicated. The mononu- 
cleosomes contained =146-bp-sized 
DNA  in  nondenaturing gel elec- 
trophoresis (data not shown, but as 
in 32). Fractions 31-39 were pooled. 
(B) Laemmli 15% SDS-PAGE of the 
histone octamers in  mononucleo- 
somes  that  had  been  stripped of 
lysine-rich histone H1.  Lanes I-5 
show successively higher loadings 
of 0.5,  1,  2,  5,  and  10/~1. 
Th Cell  VO  Junction  J/~  VB/JB  Interleuldn 
Clone  Usage  Profile 
L-1A  CASG  !)AGAA  YNSPLYFAA  8.2/1.6  IL-4 
H/L-9w.7  CASG  1JRD  Y~QFFGP  8.2/2.1  IL-2 
L-9.2  CASS  ~GQ  Y~QFFGP  8.3/2.1  IL-2 
H-16.Bll  CASG  DAPGGG  AEQFFGP  8.2/2.1  IL-2 
H-12.C4  CASS  ~KNRG  LYFGA  8.3/2.4  IL-2 
H-12.E4  CASS  D~DRGGG  TEVFFGK  8.3/1.1  IL-2 
L-3A  CASSQ  ATGG  EQYFGP  4/2.6  IL-4 + IL-2 
L-9.10  CASSQ  I~PGG  ~QFFGP  4/2.1  IL-2 
L-9.37  CASSQ  GDWG  ~QYFGP  4/2.6  IL-4 
H-15.G9  CAWS  PLPGQG~  ERLFFGH  14/1,4  IL-2 
H-15.E3  CAWS  ~QLA  NTEVFFGK  14/1.1  IL-4 
H/L-9.7  CTCS  AGLGEG  EQYFGP  2/2,6  IL-2 
H-16.B6  CTCS  AGRDQAQH  FGE  2/1.5  IL-2 
H-10.B5  CASSQ ~LGS  NTGQLYFGE  1/2.2  IL-2 
H-16.G10  CASS  QGQGAV  EQYFGP  1/2.6  IL-2 
Figure 3.  A  list of the pathogenic anti-DNA autoantibody-inducing 
Th clones derived from SNF1 mice with lupus nephritis (24).  (L-) Cloned 
lines and (H-) hybridomas directly derived from splenic T  cells.  (H/L-) 
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sulphate as described in the previous paragraph. These back- 
ground  values of $I  +  3  SD  for  the three Th  lines  that 
responded to nucleosomes were 1.4 for L-3A,  1.7 for L-9.10, 
and 1.8 for L-9.37.  In the case of the Th hybridoma clones, 
five responded significantly to nucleosomes,  and IL produc- 
tion by four of them in response to nucleosomes was as high 
as that to anti-CD3 (Table 2).  The background $I  +  3 SD 
for IL responses of these Th hybridoma clones to the non- 
stimulating autoantigens described above (synthetic V. pep- 
tides, autoantibodies, DNA, or heparan sulphate) ranged be- 
tween 3.1 and 3.9. Splenic APC (B cells plus macrophages) 
from 1-mo-old  SNF1 mice (H-2d/q),  bA  d transfected L cells, 
or A.20 B  cell  lymphoma  (H-2d),  were  equally potent  in 
presenting nucleosomal antigen(s) to these SNFl-derived Th 
Two of  the established lines had to be rescued by fusion after initial charac- 
terization. Anionic residues in the CDR3 junctional region of TCR B 
chains of the Th clones are highlighted (24).  IL profiles were determined 
in  this study. Table  1.  Responses of Cloned T  Cell Lines from Nephritic SNFI Mice to Nucleosomes 
T  cell  proliferative response (mean cpm) with: 
T  cell  APC plus  APC plus 
clone  Nuc  APC  anti-CD3  Nuc  SI 
L-1A  466*  1,016  18,631  1,028  1.0' 
L-9.2  772  1,452  5,676  1,467  1.0 
L-3A  366  821  14,389  14,806  18.0 
L-9.10  620  713  8,740  3,394  4.8 
L-9.37  609  1,349  11,093  9,996  7.4 
L-5A  369  573  15,442  553  0.9 
* Representative of 5-12 experiments. Mean cpm of triplicate cultures is given; SD within each experiment were <10%. This experiment was done 
with pure mononucleosomes (Nuc) and splenic APC from l-too-old SNF1 mice. In this and subsequent tables, APC plus Nuc means nucleosome- 
pulsed APC and APC alone means sham-pulsed APC.  Nucleosome-pulsed, irradiated APC by themselves incorporated mean cpm of 269  +  24. 
* S.I., stimulation index (see Materials and Methods). In this and subsequent tables, significant SI (>3 SD above background) are shown in boldface. 
clones (see below).  Two T  cell hybridomas that do not in- 
duce IgG anti-DNA autoantibodies are also shown in Table 
2,  because they express the  same V~ TCR  as some of the 
pathogenic Th clones that respond to nudeosomes. H-14.E7 
is  derived  from  a  nephritic  SNF1  mouse  and  uses  V~14/ 
J~2.1  genes  (24,  and Adams,  S.,  and  S.  K.  Datta,  unpub- 
lished results).  The other hybridoma,  52H10Fll,  is specific 
for insulin  and it expresses Vfl4 TCR  (39).  For the latter, 
I-A  b transfected  L  cells were used  as APC  (Table 2). 
Nucleosomal Antigen Processing and MHC Restriction.  As 
shown in Fig. 4, nucleosomal antigen presentation to the re- 
sponder Th clones requires processing via dassical MHC class 
II (MHCII) pathway. Results from the representative Th done, 
L-3A that induces pathogenic autoantibodies in vitro and is 
Table  2.  Responses of SNF~-derived T Hybridomas to Nucleosomes 
IL production  (HT-2 cpm) by T  hybridomas on culture with: 
Cloned T  APC plus  APC plus 
hybridoma  Nuc  APC  anti-CD3  Nuc  SI 
H/L-9w.7*  1,182~  1,078  28,419  28,823  26.7 
H/L-9.7  3,352  4,693  56,003  55,413  11.8 
H-12.C4  1,233  1,337  71,326  45,455  34.0 
H-16.B6  ND  565  64,020  56,093  99.2 
H-15.G9  381  875  114,622  5,081  5.8 
H-16.G10  ND  1,251  83,601  3,662  2.9 
H-16.Bll  ND  991  31,152  2,143  2.2 
H-15.E3  ND  716  118,019  942  1.3 
H-12.E4  ND  1,817  43,938  1,951  1.1 
H-10.B5  496  1,338  198,140  1,995  1.5 
H-14.E7  ND  2,088  71,703  2,037  1.0 
52H10F11  ND  5,272  97,249  4,366  0.8 
* All of the T hybridomas were derived from nephritic SNF1 mice (Fig. 3), except for the insulin-specific 52H10F11 clone from C57BL/6 (see Materials 
and Methods) and I-A  b transfected L cells were used as APC for the latter. 
Mean cpm of triplicate cultures from a representative experiment is given; the SD were <10% in each experiment. At least three experiments 
were done with each clone. This experiment was done with A.20 APC (except for hybridoma 52H10Fll) and pure mononucleosomes. Nucleosome- 
pulsed, irradiated APC by themselves did not produce ILs: 534  +  33 cpm on HT-2 cells. Similar results were obtained when splenic APC from 
1-mo-old SNF1 mice were used. 
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Figure 4.  Effect of various inhibitors of antigen processing and presen- 
tation on the proliferative response of the nephritogenic Th clone L-3A 
to mononudeosomes presented by SNF1 APC. Fixed APC were pulsed 
with antigen after fixation, whereas the order was reversed in Pulse and 
Fix APC. Anti-pan la mAb is TIB120  and its isotype-matched control 
is the anti-V/36 TCR mAb 44-22-1. 
nephritogenic in vivo (24) are shown, but similar results were 
obtained with the other pathogenic Th dories that responded 
to nudeosomes. Antigen presentation was blocked (88% in- 
hibition) by paraformaldehyde fixation of APC before pulsing 
with nucleosomes, but fixation after pulsing  with the an- 
tigen did not cause significant inhibition. The lysosomotropic 
agent chloroquine,  or the endosomal  protease  inhibitors, 
leupeptin or pepstatin A, also inhibited the Th cell response 
by 91, 60, and 71%, respectively. And leupeptin and pep- 
statin A together blocked stimulation by 87%.  Treatment 
of APC with these agents did not have a toxic effect on the 
Th cells under the conditions of the experiments, as judged 
by their response to anti-CD3 mAb, which is consistent with 
previous work (43, 44). Presentation of nucleosomal antigen(s) 
by SNF1 APC to the pathogenic Th clones was blocked by 
anti-I-A mAbs: anti-pan Ia TIB120 (anti-I-Ab'd'q, anti-I-E  d'k) 
inhibited by 97%, anti-I-A a by 95%, and anti-I-Aq by 91%, 
but the anti-I-E a mAb did not inhibit significantly (Fig. 4). 
Similar results were obtained when I-A  d transfected L cells 
or A.20 (H-2  a) lymphoma cells were used as APC for nu- 
cleosomal antigens, except that the anti-I-Aq mAb caused in- 
significant  inhibition  as  expected,  whereas  the  anti-I-A  a 
mAb caused 99.9%  inhibition (data not shown). 
In contrast to the parental strains' APC, the SNF1 APC 
(H-2d/q) were much more efficient in  presenting nucleo- 
somal antigen(s) to the SNFl-derived Th clones (Table 3). 
APC from NZB (H-2  d) did present  nucleosomes but the 
stimulation of the Th clones was much less than that with 
anti-CD3. The response of the Th clones to nucleosome-pulsed 
NZB APC could be blocked by anti-I-A  a mAb but not by 
the anti-I-Aq mAb (data not shown). The SWR (H-2q) pa- 
rental strain's APC presented nucleosomal antigens poorly and 
so did BALB/c, another H-2  a strain.  APC from C57BL/6 
(H-2  b) mice and I-A  b- or I-Ed-transfected L cells failed to 
present nucleosomal antigen(s) to these Th clones. However, 
I-A  a transfected L cells were very efficient in presenting nu- 
cleosomal antigen(s) (Table 3 and Fig. 5). Indeed,  the I-A  a 
transfected L cells were as efficient as SNF1 APC, although 
the SI with the latter were higher because the background 
cpm (Th clone plus APC without antigen) were usually lower 
than with the I-A  d L cell APC (Table 1 and Fig. 5). Results 
similar to those of the nephritogenic Th done, 3A, were ob- 
tained with the other SNFl-derived,  pathogenic autoanti- 
body-inducing Th clones that responded to nudeosomes (data 
not shown). All of the data shown in this paper were gener- 
ated in experiments where the APC were first pulsed with 
nucleosomes, then washed extensively and irradiated before 
culture with the Th cells, to exclude any nonspecific mito- 
genic effect of the nudeosomes. However, we also did cul- 
tures of Th clones with irradiated APC, where the nucleo- 
Table  3.  Nucleosomal Antigen Presentation to Pathogenic Th Clone by Different APC 
Proliferation (mean cpm) of L-3A with: 
APC plus  APC plus 
Type of APC  APC  anti-CD3  Nuc  S.I. 
SNFI*  1,593'  21,830  17,836  11.2 
NZB  590  22,752  2,215  3.8 
SWR  3,374  9,862  5,503  1.6 
C57BL/6  529  5736  521  1.0 
BALB/c  370  6,407  713  1.9 
I-AdL  1,066  13,931  10,066  9.4 
Afl~/Ecr  a L  2,009  15,150  11,673  5.8 
I-AbL  1,533  14,516  1,448  0.9 
I-E  a L  4,175  11,677  4,646  1.1 
* MHC haplotypes of APC: SNF1 (H-2d/q), NZB (H-2a),  SWR (H-2q),  C57BL/6  (h-2b),  and BALB/c (H-2d). 
* Representative experiment with the nephritogenic Th clone L-3A is shown.  Mean cpm of triplicate cultures is given; SD were <10%.  Similar 
results were obtained with the other Th clones  that responded to nucleosomes  (data not shown). 
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Figure  5.  Dose-responses  of the pathogenic Th done L-3A to nucleo- 
some presented by I-A  d L cells (A) or SNF1 APC (0). Mononucleosome 
concentrations used for pulsing the APC are given in /~g/ml DNA 
equivalent. 
somes were left continuously during the 72-h proliferation 
assay, instead of for just an initial pulse of the APC.  The 
amount of nucleosomal antigens required for maximum stim- 
ulation of the Th clones in the former cases was about 10-fold 
less  (data not  shown). 
Purified Histones Do Not Stimulate the Pathogenic  Autoantibody- 
inducing Th Clones.  The  purified  mononucleosomes  that 
stimulated these Th clones consists of DNA (=146 bp) and 
octamer of core histones (Fig. 2). Purified calf thymus DNA 
fed to the APC, either as high molecular weight DNA or 
sheared by sonication, did not stimulate any of the Th clones. 
All types of histones, such as core histone octamers purified 
from the mononucleosomes or a mixture  of total histones 
or lysine-rich histones (H1, H2A, and H2B) or arginine-rich 
histones (H3 and H4) or H2A or H2B alone,  all failed  to 
stimulate any of the Th clones significantly (data not shown). 
Nucleosome-reactive Th Clones  Augment Production of  Several 
IgG Autoantibodies.  The pathogenic Th clone L-3A, when 
cultured  with  syngeneic B  cells,  not  only augmented  the 
production of IgG anti-DNA autoantibodies as described be- 
fore (21) but also IgG autoantibodies  to histones  and his- 
tone-DNA complex (Fig. 6 A). Indeed, L-3A Th cells cocul- 
tured  with  SNF1  B  cells,  augmented  production  of IgG 
antihistone-DNA complex antibodies by 152-fold (P <0.001; 
Student's t test), but it augmented anti-ssDNA, anti-dsDNA, 
and antihistone antibody production by 18.8-, 13-, and 6-fold, 
respectively (P <0.01).  Similar results were obtained with 
other pathogenic autoantibody-inducing Th cells from SNF1 
mice (data not shown).  Help by the autoimmune Th cells 
for the  production  of either  cross-reacting  anti-DNA  an- 
tibodies or the production of different population of autoan- 
tibodies  could  explain  this  result.  Therefore,  prototypic 
anti-DNA mAbs that are pathogenic and recurrently expressed 
in nephritic SNF1 mice (2, 4, 7) were also tested (Fig.  6 B). 
The pathogenic anti-DNA mAb 564 that cross-reacts with 
several nucleic acid antigens (52), also bound strongly to his- 
tones and histone-DNA complexes, and this binding could 
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Figure 6.  (A) Helper activity of the nephritogenic Th clone L-3A de- 
rived from SNF1 mice with lupus nephritis. (Bars) Fold  increases (log scale) 
in the production of IgG autoantibodies when the Th cells were cultured 
with syngeneic  B cells  as compared  with B cells  cultured alone. (Hist/DNA) 
Histone-DNA complex. (B) ELISA showing the binding of the proto- 
typic, pathogenic anti-DNA mAb 564 of SNF1 mice to ssDNA (&), 
dsDNA (O), histones (A), and histone-DNA complex (1). The same 
mAb was digested with DNAse I and its binding to wells coated with 
histones that had also been digested with DNAse I is shown (I-q). 
not be significantly reduced by DNAse digestion using de- 
scribed procedures (48). Similar results were obtained with 
other pathogenic anti-DNA autoantibodies of SNFt mice (2, 
4, 7) that bind both ssDNA and dsDNA and belong to the 
major  Id564 family (data not  shown). 
T Cells Reactive to Nudeosomal Antigens Are Present in the 
Spleens of Lupus Mice.  Fresh CD4 + T  cells obtained from 
the spleens of SNF1 and BWF, lupus-prone mice responded 
significantly to nucleosomes ex vivo, whereas splenic T cells 
from nonautoimmune  strains or the NZB mice that rarely 
develop lupus nephritis  failed to respond (Table 4). T  cells 
from 3-mo-old NZB were tested before their spleens became 
abnormal from hemolytic anemia. The mean background SI 
+  3 SD of SNF1 T cells to the nonstimulatory antigens de- 
scribed above (V, region peptides, autoantibodies, etc.) was 
1.6 and the corresponding value for T cells from the normal 
strains  and NZB mice was  1.7.  CD8 §  T  cells  did not re- 
1374  Lupus  T Cells Recognize Nucleosomes Table 4.  Responses of  CD4 + T  Cells from the Spleens of lZ~'fferent Mouse Strains to Nucleosomal Antigens 
Proliferation in mean cpm and (SI) of CD4 § T cells cultured with: 
APC plus  APC plus  APC plus 
Source of T cells  Nuc  APC  oeCD3  Nuc  Histones 
SNF1,  1 mo  1,378  _+  437*  3,064  _+  761 t  42,273  _+  6,156  10,791  _+  1,493  4,328  +  796  s 
(3.5)  (1.4) 
SNF,,  2  mo  1,921  _+  575  3,533  _+  896  97,327  _+  10,450  19,263  _+  4,864  17,645  _+  3,243 
(5.5)  (5.0) 
SNF~,  4  mo  ND  2,541  _+  746  159,894  _+  16,147  13,977  _+  556  ND 
(5.5) 
SNFb  6  mo  1,404  +  108  2,421  _+  518  72,927  _+  6,861  20,249  _+  4,385  25,659  -+  3,979 
(8.4)  (10.6) 
BWF~, 2 mo  1,147  .+ 370  3,414  _+  143  42,555  +  5,582  14,375  .+  2,993  4,941  .+  638 
(4.2)  (1.5) 
NZB,  3 mo  1,280  ,+  84  1,524  _+  139  47,926  _+  5,259  1,981  _+  181  1,518  ,+ 365 
(1.3)  (1.0) 
SWR, 6 mo  9,412  _+  762  10,670  _+  1,286  150,608  _+  16,532  10,340  .+  2,488  9,950  _+  1,019 
(1.0)  (0.9) 
BL/6, 5 mo  562  _+  89  917  ,+  102  55,527  ,+  6,842  975  .+  155  630  _+  178 
(1.1)  (0.7) 
BALB/c,  4  mo  680  ,+  53  1,521  +  155  48,962  ,+  7,944  1,996  +  442  1,171  ,+  205 
(1.3)  (0.8) 
*  Results from 3-5 experiments.  Significant proliferation  shown in boldface. 
t Splenic APC from 1-mo-old mice of respective strains were used. Nucleosome-pulsed and irradiated SNF1 APC by themselves incorporated 269  _+ 24 
cpm and BWF1 APC, 236  -+ 37 cpm. 
S Mixture of histones  H1,  H2A, and H2B.  Similar results were  obtained  with total histones. 
spond to the nucleosomal antigens (data not shown). In these 
experiments, T cell-depleted splenocytes from 1-mo-old mice 
of each strain were used as APC for their respective T cells, 
and they were pulsed with the nucleosomal antigens, washed 
extensively,  and irradiated before culture with the T  cells. 
Under such conditions, the antigen-pulsed APC did not stimu- 
late syngeneic B cells from spleen (data not shown). Moreover,  ;~ 
the nucleosomes did not stimulate the purified, splenic T cells 
directly (Table 4).  ;~ 
The SNF1 mice had nucleosome-primed T  cells as early 
as 1 mo of age and the SI increased  significantly by 2 mo  = 
(P <0.001; Student's t test). The SI to nucleosomes at 6 mo 
were even greater than at 2 or 4 mo of age (P <(0.001; Table 
4). At 2 mo of age (but not at 1 mo), the SNFI T cells also 
had a population that responded significantly to histones,  " 
and the SI to histones increased  markedly by 6 mo of age  "~ 
(P <0.001). At 2 mo of age the BWF1 lupus mice also had  .~ 
a significant T cell response to nucleosomes, but not to his- 
tones (Table 4). The response of the lupus T cells to nucleo- 
somes presented by the APC could be blocked by anti-I-A  a 
mAb  and similar results were obtained when I-A  d trans- 
fected L cells were used as APC (data not shown). 
Nudeosomes Accelerate the Development  of Severe Glomerulo- 
nephritis  in  SNFI  Mice.  2-mo-old  preautoimmune SNF1 
mice injected with purified mononucleosomes in adjuvant 
developed  severe nephritis much earlier  than age-matched 
SNF1 mice injected with PBS in adjuvant (Fig. 7). The mice 
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Figure 7.  Incidence of severe lupus nephritis in SNF1 mice immunized 
with mononucleosomes (Nuc) or saline (PBS). The mice received the last 
booster  injection at 12 wk of age. 
1375  Mohan et al. in Fig. 7 were considered to have severe glomerulonephritis 
when they had persistent proteinuria of 300 mg/dl or above 
for at least 2 wk and BUN levels at 30 mg/dI or above, and 
upon killing at  this  stage,  their kidneys showed a 3+-4 + 
grade of nephritis by histopathology and a 3 +-4 + degree of 
immune deposits by immunofluorescence (20). By 6 mo of 
age, =71.4% of the nucleosome-injected mice developed se- 
vere lupus nephritis, in contrast to --6.6% of the controls 
(P <0.001), and by 9 mo, 100% of the former mice had se- 
vere nephritis as compared to 53% of the controls (P <0.05). 
The incidence of lupus nephritis in the control SNF1 group 
injected with PBS in adjuvant (Fig.  7), was similar to that 
of uninjected SNF1 mice (20). 
Levels oflgG class autoantibodies in serum were measured 
at about the midpoint of the study, 3 mo after immuniza- 
tion when the surviving mice were ~6 mo of age (Table 5). 
Serum samples obtained from killed mice that had developed 
severe nephritis earlier were also included. By this age,  the 
nucleosome-injected mice had significantly higher levels of 
IgG anti-ssDNA and antihistone antibodies than the PBS- 
injected group overall (P <0.005;  Mann-Whitney U  test). 
However, differences in anti-dsDNA levels in serum were not 
significant, as was the case with antibodies to histone-DNA 
complex (P <0.1). The latter result was due to the marked 
variation in autoantibody levels in the nucleosome-injected 
mice, but their mean value was about 10-fold higher than 
that of the control group. This variation is expected since 
some of the nucleosome-injected mice had already developed 
severe nephritis by this age whereas others had not. Even those 
with severe nephritis did not always have high levels of serum 
Table 5.  IgG Autoantibodies in  the Serum  of SNF,  Mice 3  mo after Immunization 
Serum levels of IgG autoantibodies against: 
Mice  ssDNA  dsDNA  Histones  Histone/DNA 
U/ml 
Nucleosome-injected mice 
NI*  2.3  2.22  30.78  1.53 
N2*  1.9  2.22  37.04  11.76 
N3  110.72  2.57  61.60  0.50 
N4  58.9  39.74  27.62  50.20 
N5*  141.98  2.49  216.96  15.20 
N6*  6.43  2.00  2.36  0.30 
N7*  1.92  3.36  13.43  2.95 
Mean  _+  SEM  46.31  _+  20.67  7.80  _+  4.93  55.68  +  25.72  11.78  +_  6.27 
Saline (PBS)-injected mice 
$1  0.99  2.33  2.20  0.51 
$2  0.77  2.38  3.19  0.94 
$3  31.59  2.67  11.21  0.50 
$4"  19.12  2.62  20.02  1.63 
$5  38.90  2.74  6.06  3.20 
$6  2.34  2.70  8.80  1.51 
$7  0.85  2.58  9.35  1.97 
$8  0.68  2.37  13.16  1.21 
$9  0.93  2.71  4.12  1.33 
$10  1.45  2.53  22.65  2.60 
$11  0.19  0.13  0.61  0.17 
$12  0.53  0.13  2.45  0.32 
$13  0.93  2.09  25.81  1.34 
$14  0.59  2.25  2.59  0.57 
$15  1.92  1.47  3.19  0.41 
Mean  •  SEM  6.78  •  3.03  2.11  •  0.22  9.03  •  2.09  1.21  +_  0.21 
* Sera from these animals were obtained earlier when they developed severe nephritis (Fig. 7). 
1376  Lupus  T Cells Recognize Nucleosomes autoantibodies (Table 5), suggesting that the autoantibodies 
were probably deposited in tissues. Splenic CD4 + T cells of 
SNF1 mice from both groups responded strongly to nucleo- 
somes since they were obtained from mice that were killed 
when they developed severe nephritis (data not shown). 
Discussion 
These studies show that the nucleosome is a major im- 
munogen for the pathogenic autoantibody-inducing Th cells 
that arise spontaneously in lupus. The mechanism of autoim- 
munization by nudeosomes was so far unknown. Nudeo- 
somes were suspected to be immunogens in lupus because 
they were detected in immune complexes with anti-DNA 
autoantibodies (53-55), but this phenomenon could occur 
secondarily because of indirect binding of the autoantibodies 
via DNA in the nucleosomes (50, 56). Even in normal indi- 
viduals,  most of the circulating DNA is found as part of 
oligonucleosomes that are released after apoptosis.  Indeed, 
patients undergoing lifelong, chronic hemodialysis release large 
amounts of DNA in circulation as oligonudeosomes  without 
developing lupus (57). Moreover,  nucleosomes were found 
to stimulate B cells nonspecificaUy as a polyclonal mitogen, 
but this effect applied equally to B cells from lupus strains 
as well as normal mice, thus arguing against a specific role 
of nudeosomes in the pathogenesis of SLE (33, 34). Indeed, 
polyclonal mitogenic stimulation of B cells by nudeosomes 
would not explain the IgG class switch, somatic mutation, 
and donal expansion of pathogenic anti-DNA B cells in lupus 
that are characteristic  of an antigen-driven response (5-10). 
Our results for the first time show an antigen- and lupus- 
specific responsiveness of pathogenic autoantibody-inducing 
Th cells to nudeosomes. Not only pathogenic Th clones de- 
rived from nephritic lupus mice but also fresh splenic T cells 
from two different lupus strains were found to respond to 
nucleosomes. The CD4 + T  calls from lupus mice were al- 
ready primed in vivo to this major autoantigen as early as 
1 mo of age, long before autoantibodies and glomerulone- 
phritis are detectable in these strains of mice. It is noteworthy 
that these types ofT cells were not detectable in normal strains 
or in the autoimmune NZB parental strain  that rarely de- 
velops nephritis. Thus, the presence of nucleosome-specific 
T cells predicts the development of hpus nephritis well in 
advance of other markers of the disease. Moreover, injection 
of nucleosomes into young preautoimmune SNF1 mice led 
to increased autoantibody production and accderation of se- 
vere lupus nephritis. This result could be in part due to poly- 
clonal stimulation orb cells in vivo (33). However, injection 
of nudeosomes into normal mice whose B cells are also poly- 
clonally stimulated by it or by injection of nucleosomes into 
rabbits does not result in the production of lupus-specific anti- 
DNA autoantibodies or nephritis. Mostly antihistone anti- 
bodies are produced in such normal animals (58-60). There- 
fore, the nucleosome-specific  Th cells that are present only 
in the lupus-prone mice are necessary for the production of 
pathogenic autoantibodies and acceleration  of nephritis. 
About half of the pathogenic autoantibody-inducing Th 
clones  from SNF1 mice were specific for nucleosomal an- 
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tigen(s).  These special autoimmune Th clones are predomi- 
nantly CD4 +. They arose spontaneously in the lupus mice 
with nephritis and they were a minor fraction of autoreac- 
tire T cells that were activated in vivo (24).  These patho- 
genic Th calls were represented not only among cloned T 
cell lines but also among T cell hybridomas that rescued the 
in vivo-activated T  cells directly from the nephritic lupus 
mice. These autoimmune Th clones not only had the func- 
tional ability to induce pathogenic anti-DNA autoantibodies 
in vitro like the freshly isolated T cells from the spleens of 
nephritic lupus mice, but they could also rapidly induce lupus 
nephritis when transferred into preantoimmune mice (12, 24). 
It is interesting that the majority of these autoimmune Th 
clones have the IL profile of Thl cells. Thl cells help in the 
production of IgG2a antibodies (61) and the major subclass 
of pathogenic anti-DNA autoantibodies found in the renal 
lesions of these lupus mice is IgG2a (2). However, some of 
the pathogenic Th clones were Th2 type, and lymphokines 
produced typically by Th2 cells are also known to be impor- 
tant in pathogenic autoantibody production (16, 62). Like 
our pathogenic Th clone L-3A,  anti-DNA autoantibody- 
inducing Th clones with Th0 IL profile have also been iso- 
lated from other lupus mice (63). 
The nudeosomes did not have any direct mitogenic effect 
on the T  cells and since the nudeosome-specific Th clones 
expressed diverse TCR Vl3 genes, it is unlikely that nudeo- 
somes provide a superantigen for the T cells. Moreover, other 
T cell clones expressing the same V/3 TCR as the responders 
(V/3 4, 8.2, 8.3, or 14) failed to respond to nudeosomes. The 
presentation of nucleosomal antigens could be blocked by 
paraformaldehyde fixation or chloroquine treatment of the 
APC, indicating that they are processed by the classical en- 
dosome/lysosome  MHCII pathway (43). The purified mono- 
nudeosomes that stimulated the Th cells consisted of only 
DNA (w-146 bp) and core histones.  Yet, neither free DNA 
nor histones stimulated any of the Th clones. This result sug- 
gests that the nucleosomes as a whole are taken up for pro- 
cessing more e~ciently either by special nudeosome  receptors 
on the APC (64) or by the anti-DNA autoantibody receptors 
on the lupus B cdls (Fig. 1). However, since I-A  a L cells can 
present nucleosomal antigens efficiently, we have to postu- 
late the ubiquitous presence  of the nucleosomal receptors. 
An alternative possibility is that during antigen processing, 
critical Th cell epitopes in the histones are protected from 
degradation by being bound to DNA in the nucleosomes, 
as it occurs in other immunogens (65). The fact that antigen 
presentation could be blocked by leupeptin and pepstatin A, 
inhibitors of the endosomal proteases,  cathepsin B and D, 
respectively (44), also suggests that a peptide(s) from the his- 
tone component of the nucleosomes contain the relevant epi- 
tope(s) for the pathogenic Th ceils. The splenic T cells from 
older SNF1 that responded to pure histones probably belong 
to a different subset than those responding to nucleosomes 
(Table 4), because  splenic T  cells from l-too-old SNF1 or 
young B/WF1  mice and the SNFl-derived Th clones  de- 
scribed above respond to nudeosomes only. The former subset 
of T cells may be specific for different epitopes on the his- 
tones than the nucleosome-specific  Th cells, and they may be involved in the production of those autoantibodies that 
are specific for histones, but do not cross-react with DNA 
(66,  67). 
The APC from young SNF1 mice could present nudeo- 
soma] antigens much more efficiently to the SNFl-derived 
Th clones than either of the parental straiffs (NZB or SWR) 
APC. More efficient antigen uptake due to the presence of 
anti-DNA B cells or cells with a higher density of nucleo- 
some receptors in the SNF1 APC could explain this result. 
However,  the presentation of nucleosome by SNFx APC to 
the Th cells could be blocked equally by either anti-I-A  a or 
anti-I-Aq  mAbs, suggesting that Fl-hybrid I-A molecules 
may be involved in presenting the T cell epitopes. This finding 
is consistent with previous results showing that the pathogenic 
Th clones would spontaneously proliferate more vigorously 
when cultured with APC from older nephritic SNF1 mice 
than either of the parental strains' APC (21), and among the 
F2 and backcross  progeny of SWR  ￿  NZB  crosses, the 
progeny mice with F1 heterozygous MHC  haplotype de- 
velop accelerated and severe nephritis (49). The pathogenic 
anti-DNA B cells that are expanded only in the older SNF1 
mice (but not in the parental strains) could present endoge- 
nous nucleosomal antigens much more efficiently to the Th 
(Hg. 1). However, nudeosome-specific T cells are present even 
in younger lupus mice, suggesting that the Th cells could 
be primed by other APC before their cognate interaction with 
the anti-DNA B cells. Indeed, I-A  d L cells and A.20 lym- 
phoma cells could also present nucleosomal antigens efficiently 
to the Th clones, in contrast to splenic APC from BALB/c 
and NZB mice which are also H-2  a. The former continuous 
cell lines might be better in the uptake and/or processing 
of the complex nudeosomal antigens because of unknown 
reasons. The fact that I-A  ~ molecules are as good as I-Aa/q 
(SNFl-type) molecules in presenting nucleosomal epitopes 
to the SNFl-derived Th clones suggests that these antigenic 
epitopes  are  promiscuous,  i.e.,  the  same  epitope can  be 
presented by different MHCII molecules even to the same 
T  cell clone (68,  69).  However,  since I-A  a and I-Aq mole- 
cules are very homologous in structure in the regions that 
contact antigenic peptide and the TCR (70), they could both 
present the same T  cell epitope to the same SNFl-derived 
Th clone.  Indeed, T  cell clones specific for a peptide from 
cytochrome c can also respond equally to that peptide presented 
by I-E molecules of either k or b haplotype (71). However, 
in the SNF1 mouse itself,  the I-Ad/q hybrid molecules are 
probably more effective in competing for nudeosomal an- 
tigen presentation than I-A  ~/a molecules (Fig.  4;  21, 49). 
These hypotheses can be tested further with I-Aq or I-Aa/q 
transfected  L cells which are not yet available. 
The Th clones that responded to the nucleosomes expressed 
different TCR VB genes with different CDR3 junctional se- 
quences. This heterogeneity would suggest that several pep- 
tide epitopes are generated from the complex nudeosomal 
antigen. However, the TCR repertoire for even a single pep- 
tide antigen can be highly diverse (72), and just a single res- 
idue change in an antigenic peptide would lead to usage of 
diverse TCR V~ genes by the responding T  cells demon- 
strating the plasticity of TCR repertoire (26). Thus, unlike 
experimentally induced autoimmune  diseases, TCR V~ usage 
by pathogenic T cells in spontaneous, systemic autoimmune 
diseases is usually heterogeneous. 
About 50%  of the SNFl-derived Th clones did not re- 
spond to nudeosomes, indicating that other antigens are also 
involved in the pathogenic autoimmune  response. This com- 
plexity is expected in a spontaneous and systemic autoim- 
mune disease like lupus. We tested the second possibility that 
some of these Th clones are idiotype-specific  (Fig.  1). Nei- 
ther intact pathogenic anti-DNA autoantibodies (mAbs) that 
are expressed recurrently in the nephritic SNF1 mice (2, 4, 
7), nor synthetic peptides derived from the V.-CDR regions 
that are shared by the pathogenic autoantibodies could stimu- 
late the Th clones or fresh splenic T cells from either young 
or older nephritic SNF1 mice. These synthetic idiopeptides 
contained cationic residues and T cell epitope motifs. How- 
ever, self-idiotypes may be processed by the endogenous path- 
way in the autoimmune B cells (28), and thus may generate 
other idiopeptide epitopes. Even if such idiotype-specific Th 
ceils are found in lupus, they would arise secondarily,  since 
antigen-driven expansion and somatic mutation of the au- 
toantibodies have to occur in the first place to generate such 
CDR idiopeptides. None of the Th clones responded to free 
DNA or polyanions like heparan sulphate proteoglycan that 
crossreact with anti-DNA autoantibodies. 
The nudeosome-specific Th cells interact with and help 
the pathogenic anti-DNA autoantibody producing B cells 
preferentially, rather than any B cells producing IgG (22, 24). 
In spontaneous or drug-induced SLE, certain B cells produce 
autoantibodies that bind nudeosomes better than either free 
histones or DNA (45-47, 73). On the other hand, other B 
cells of lupus produce anti-DNA autoantibodies that bind 
to nucleosomes and histones via DNA (50, 56). The SNF1- 
derived pathogenic autoantibodies  of 564 family probably be- 
long to the latter category. Their binding to histones could 
not be significantly diminished even after DNAse digestion, 
probably because some DNA bound by the autoantibodies 
in  culture would remain protected from digestion (48). 
Nevertheless, both types of autoimmune B cells would present 
the nucleosomal autoantigen(s) to the pathogenic Th cells 
much more efficiently than other APC during the ongoing 
autoimmune response in lupus. Indeed, the pathogenic Th 
clones  from nephritic SNF1 mice not  only augment the 
production of IgG anti-DNA autoantibodies but antihistone 
and antinucleosome (histone-DNA complex) antibodies as 
well. 
Nucleosome is a naturally occurring and abundant partic- 
ulate autoantigen generated by apoptosis of cells that happens 
daily. Particulate autoantigens from nucleus appear to be the 
target  of autoantibodies (74).  Now we have functionally 
characterized T cell clones of proven pathogenic role in lupus 
and the appropriate APC for the presentation of nudeosomal 
antigen to these T cells. We can therefore elute the naturally 
processed peptide, study the breakdown of tolerance to the 
autoantigen, and design ways to intervene against this patho- 
genic autoimmune response in lupus. 
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